A randomized open label pilot study to compare the efficacy of the desidustat with erythropoietin in patients of anaemia with dialysis naive chronic kidney disease

Dr Hiramani Rabha0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•1)Patient of either sex and aged >= 18years
•2)Patients with anaemia (Hb <= 9g/dl) with Chronic Kidney Disease stage III-V not on hemodialysis or peritoneal dialysis , with adequate iron stores (ferritin, TSAT)
•3)Patients willing to give informed consent

•1)Patients with hyperkalemia (documented either in biochemical tests or ECG)
•2)History of haematological disorders like uncontrolled autoimmune hemolytic anaemia, idiopathic thrombocytopenic purpura (ITP) or thalassemia
•3)Red blood cell transfusion within 6 weeks prior to participating in the study
•4)History or presence of any clinically significant electrocardiogram (ECG) abnormalities during screening
•5)History of allergic reactions attributed to compounds of similar chemical or biologic composition of Desidustat or erythropoietin
•6)Currently active clinically significant cardiovascular disease such as uncontrolled arrhythmia, congestive heart failure, any class 3 or 4 cardiac disease as defined by the New York Heart Association Functional Classification
•7)Current infectious disease like active hepatitis, active tuberculosis etc.
•8)Pregnant and breastfeeding women

发起方

Dr Hiramani Rabha